ATC Group: V09IX11 Fluoroestradiol (18F)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IX11 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IX Other diagnostic radiopharmaceuticals for tumour detection
5 V09IX11

Active ingredients in V09IX11

Active Ingredient Description
Fluoroestradiol ¹⁸F

Fluoroestradiol ¹⁸F binds estrogen receptor (ER) and is indicated for use with positron emission tomography (PET imaging) for characterization of ER status of known or suspected metastatic lesions in patients with confirmed ER-positive breast cancer.

Medicines in this ATC group

France (FR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.